Philadelphia, United States
Accelerated Biosciences Corp. is a company specializing in the commercialization of human trophoblast stem cells, derived from the trophectoderm of embryos from women with ectopic pregnancies. These ethically sourced hTSCs possess immune-privileged characteristics, making them a valuable and abundant pluripotent stem cell platform for various applications such as basic research, disease modeling, toxicology, drug discovery, and cell therapy.
The company, based in the United States, holds great promise in the field of biotechnology and regenerative medicine. Its pioneering work in the utilization of hTSCs opens up opportunities for breakthrough advancements in healthcare and life sciences.
